Literature DB >> 8458668

Cardiac pathology in patients with end-stage renal disease maintained on hemodialysis.

A Ansari1, C J Kaupke, N D Vaziri, R Miller, A Barbari.   

Abstract

We report the spectrum of cardiovascular pathology found on autopsy examination in 106 consecutive patients with end-stage renal disease. Cardiovascular pathology was present in nearly all patients, and was the most frequent cause of death (36%), with acute myocardial infarction accounting for 15%. Particularly frequent pathologic findings were left ventricular hypertrophy, coronary and aortic atherosclerosis, pericarditis with effusion, myocardial fibrosis, and valvular dilatation. Cardiovascular death rate was higher during the first year than after the fifth year of dialysis. Nearly all patients had a history of hypertension. The nature of the underlying cause of renal failure and pre-existing cardiovascular disease, specifically diabetes mellitus and hypertension, were the principal predictors of cardiovascular mortality rather than maintenance hemodialysis therapy per se.

Entities:  

Mesh:

Year:  1993        PMID: 8458668

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  13 in total

Review 1.  Atherosclerosis in CKD: differences from the general population.

Authors:  Tilman B Drüeke; Ziad A Massy
Journal:  Nat Rev Nephrol       Date:  2010-10-26       Impact factor: 28.314

2.  QT dispersion predicts mortality and correlates with both coronary artery calcification and atherosclerosis in hemodialysis patients.

Authors:  Murat Guney; Abdullah Ozkok; Yasar Caliskan; Hamdi Pusuroglu; Halil Yazici; Savas Tepe; Huseyin Oflaz; Alaattin Yildiz
Journal:  Int Urol Nephrol       Date:  2013-09-14       Impact factor: 2.370

3.  Pathogenesis of arrhythmias in a model of CKD.

Authors:  Chia-Hsiang Hsueh; Neal X Chen; Shien-Fong Lin; Peng-Sheng Chen; Vincent H Gattone; Matthew R Allen; Michael C Fishbein; Sharon M Moe
Journal:  J Am Soc Nephrol       Date:  2014-05-22       Impact factor: 10.121

4.  Relationship between major adverse cardiac events and angiographic findings in dialysis patients.

Authors:  F Fabbian; G Cacici; V De Biase; T Yabarek; C Gangemi; L Franceschini; A De Giorgi; P Benussi; A Lupo; F Portaluppi
Journal:  Int Urol Nephrol       Date:  2010-09-02       Impact factor: 2.370

5.  Dialytic interval and the timing of electrocardiographic screening for subcutaneous cardioverter-defibrillator placement in chronic hemodialysis patients.

Authors:  Cindy You; Shishir Sharma; Aakash Bavishi; Christopher A Groh; Yazan Alia; Basil Saour; Rod Passman
Journal:  J Interv Card Electrophysiol       Date:  2018-03-10       Impact factor: 1.900

6.  Diagnosis, pathogenesis, treatment, and prognosis of hereditary fibrinogen A alpha-chain amyloidosis.

Authors:  Julian D Gillmore; Helen J Lachmann; Dorota Rowczenio; Janet A Gilbertson; Cai-Hong Zeng; Zhi-Hong Liu; Lei-Shi Li; Ashutosh Wechalekar; Philip N Hawkins
Journal:  J Am Soc Nephrol       Date:  2008-12-10       Impact factor: 10.121

Review 7.  Calcium as a cardiovascular toxin in CKD-MBD.

Authors:  Sharon M Moe
Journal:  Bone       Date:  2016-08-27       Impact factor: 4.398

8.  Is valvular calcification a part of the missing link between residual kidney function and cardiac hypertrophy in peritoneal dialysis patients?

Authors:  Angela Yee-Moon Wang; Christopher Wai-Kei Lam; Mei Wang; Iris Hiu-Shuen Chan; Siu-Fai Lui; John E Sanderson
Journal:  Clin J Am Soc Nephrol       Date:  2009-08-27       Impact factor: 8.237

9.  Subcutaneous nerve activity and mechanisms of sudden death in a rat model of chronic kidney disease.

Authors:  Ye Zhao; Neal X Chen; Jonathan T Shirazi; Changyu Shen; Shien-Fong Lin; Michael C Fishbein; Sharon M Moe; Peng-Sheng Chen
Journal:  Heart Rhythm       Date:  2015-12-29       Impact factor: 6.343

10.  The association between kidney function, coronary artery disease, and clinical outcome in patients undergoing coronary angiography.

Authors:  Ki Young Na; Chi Weon Kim; Young Rim Song; Ho Joon Chin; Dong-Wan Chae
Journal:  J Korean Med Sci       Date:  2009-01-28       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.